课题基金 / 基金详情

Targeted Clinical Trials To Reduce the Risk of Antimicrobial Resistance

Targeted Clinical Trials To Reduce the Risk of Antimicrobial Resistance
降低抗生素耐药性风险的针对性临床试验
批准号：
8605129
负责人：
ALEHANDRO HOBERMAN
金额：
$41.07万
依托单位：
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
依托单位国家：
美国
项目类别：
财政年份：
2010
资助国家：
美国
项目状态：
已结题
起止时间：
2010-09-24 至 2013-12-31
来源：
https://reporter.nih.gov/project-details/8605129
关键词：
AntibioticsAntimicrobial ResistanceChildhoodClinical TrialsDrug ExposureDrug resistanceHaemophilus influenzaePopulationProbabilityRegimenRiskdesignsafety testingtherapeutic effectiveness

项目摘要

项目成果

ALEHANDRO HOBERMAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
To evaluate strategies that test the safety and effectiveness of therapeutic approaches/regimens to reduce the probability of the emergence of antibiotic drug resistance by minimizing unnecessary drug exposure.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeted Clinical Trials to Reduce the Risk of Antimicrobial Resistance
Targeted Clinical Trials to Reduce the Risk of Antimicrobial Resistance
Targeted Clinical Trials to Reduce the Risk of Antimicrobial Resistance
Targeted Clinical Trials to Reduce the Risk of Antimicrobial Resistance
海外基金